Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.3M Buy
518,373
+126,076
+32% +$2.92M ﹤0.01% 1390
2025
Q4
$9.13M Buy
392,297
+166,453
+74% +$4.01M ﹤0.01% 1745
2025
Q3
$6.39M Buy
225,844
+116,141
+106% +$3.09M ﹤0.01% 2008
2025
Q2
$2.41M Sell
109,703
-7,782
-7% -$170K ﹤0.01% 2703
2025
Q1
$2.74M Sell
117,485
-62,174
-35% -$1.59M ﹤0.01% 2391
2024
Q4
$5.16M Buy
179,659
+71,729
+66% +$2.15M ﹤0.01% 2138
2024
Q3
$3.2M Buy
107,930
+38,027
+54% +$1.18M ﹤0.01% 2463
2024
Q2
$2.36M Sell
69,903
-161,944
-70% -$5.59M ﹤0.01% 2019
2024
Q1
$8.37M Buy
231,847
+30,848
+15% +$1.07M ﹤0.01% 1521
2023
Q4
$6.56M Buy
200,999
+83,203
+71% +$2.57M ﹤0.01% 1868
2023
Q3
$3.83M Sell
117,796
-20,770
-15% -$666K ﹤0.01% 1500
2023
Q2
$4.05M Buy
138,566
+89,836
+184% +$2.48M ﹤0.01% 1463
2023
Q1
$1.37M Buy
48,730
+16,637
+52% +$469K ﹤0.01% 2505
2022
Q4
$875K Sell
32,093
-47,618
-60% -$1.27M ﹤0.01% 2915
2022
Q3
$1.9M Sell
79,711
-16,088
-17% -$442K ﹤0.01% 1783
2022
Q2
$2.68M Buy
95,799
+78,823
+464% +$2.29M ﹤0.01% 1655
2022
Q1
$495K Sell
16,976
-30,663
-64% -$954K ﹤0.01% 2916
2021
Q4
$1.66M Sell
47,639
-77,497
-62% -$2.75M ﹤0.01% 2495
2021
Q3
$4.13M Sell
125,136
-145,414
-54% -$4.7M ﹤0.01% 1758
2021
Q2
$8.95M Buy
270,550
+108,945
+67% +$3.78M ﹤0.01% 1251
2021
Q1
$5.76M Buy
161,605
+144,854
+865% +$5.15M ﹤0.01% 1404
2020
Q4
$568K Sell
16,751
-62,694
-79% -$1.93M ﹤0.01% 3166
2020
Q3
$2.04M Sell
79,445
-12,568
-14% -$334K ﹤0.01% 2079
2020
Q2
$2.37M Buy
92,013
+29,813
+48% +$747K ﹤0.01% 1956
2020
Q1
$1.38M Sell
62,200
-53,359
-46% -$1.48M ﹤0.01% 2632
2019
Q4
$3.35M Buy
115,559
+5,618
+5% +$158K ﹤0.01% 2445
2019
Q3
$3.03M Sell
109,941
-131,015
-54% -$3.46M ﹤0.01% 2378
2019
Q2
$5.93M Buy
240,956
+7,599
+3% +$172K ﹤0.01% 1723
2019
Q1
$4.83M Buy
233,357
+17,300
+8% +$362K ﹤0.01% 1690
2018
Q4
$4.37M Sell
216,057
-198,529
-48% -$4.16M ﹤0.01% 1685
2018
Q3
$8.9M Sell
414,586
-106,550
-20% -$2.47M 0.01% 1338
2018
Q2
$12M Buy
521,136
+160,262
+44% +$3.8M 0.01% 1100
2018
Q1
$8.31M Buy
360,874
+248,215
+220% +$5.65M 0.01% 1286
2017
Q4
$2.36M Buy
112,659
+49,393
+78% +$983K ﹤0.01% 2282
2017
Q3
$1.25M Buy
63,266
+56,441
+827% +$1.03M ﹤0.01% 2798
2017
Q2
$129K Sell
6,825
-83,304
-92% -$1.62M ﹤0.01% 4732
2017
Q1
$1.92M Buy
90,129
+57,523
+176% +$1.21M ﹤0.01% 2143
2016
Q4
$642K Buy
32,606
+11,954
+58% +$218K ﹤0.01% 3147
2016
Q3
$363K Sell
20,652
-15,433
-43% -$267K ﹤0.01% 3500
2016
Q2
$558K Buy
36,085
+29,040
+412% +$461K ﹤0.01% 3120
2016
Q1
$105K Sell
7,045
-1,642
-19% -$23.9K ﹤0.01% 4313
2015
Q4
$139K Sell
8,687
-52,560
-86% -$849K ﹤0.01% 4180
2015
Q3
$919K Sell
61,247
-10,761
-15% -$171K ﹤0.01% 2795
2015
Q2
$1.15M Sell
72,008
-41,348
-36% -$723K ﹤0.01% 2760
2015
Q1
$2.04M Buy
113,356
+75,598
+200% +$1.33M ﹤0.01% 2299
2014
Q4
$679K Buy
37,758
+17,844
+90% +$296K ﹤0.01% 3555
2014
Q3
$259K Sell
19,914
-17,300
-46% -$252K ﹤0.01% 4506
2014
Q2
$539K Buy
37,214
+29,364
+374% +$429K ﹤0.01% 3899
2014
Q1
$122K Sell
7,850
-103,974
-93% -$1.66M ﹤0.01% 5267
2013
Q4
$1.79M Sell
111,824
-72,868
-39% -$1.07M ﹤0.01% 2793
2013
Q3
$2.31M Sell
184,692
-123,504
-40% -$1.46M ﹤0.01% 2409
2013
Q2
$3.55M Buy
+308,196
New +$3.47M ﹤0.01% 1928

Other funds holding GNTX

Barclays's GNTX Position: Q1 2026 in Review

Barclays increased its Gentex (GNTX) stake by 32% in Q1 2026, buying an estimated $2.92M and bringing the position to 518,373 shares worth $11.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1390.

Barclays first reported a position in GNTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $12M in Q2 2018. 503 funds tracked by Wall St. Rank hold GNTX as of Q1 2026.

  • Barclays held 518,373 shares of Gentex worth $11.3M as of Q1 2026.
  • Barclays bought 126,076 Gentex shares in Q1 2026, an estimated $2.92M.
  • Gentex made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1390 holding.
  • Barclays first reported a position in Gentex in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Gentex position peaked at $12M in Q2 2018.
  • 503 funds tracked by Wall St. Rank held Gentex as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.